Home Newsfeeds Dollar Tree Executive Says In Q2, Consumables Comps Increased 4% While Discretionary Comps Declined 4.1%

News

Dollar Tree Executive Says In Q2, Consumables Comps Increased 4% While Discretionary Comps Declined 4.1%

-Reuters

byBenzinga Newsdesk

August 25, 2022

1 minute read

-Reuters

Viracta Therapeutics To Present Topline Nana-val Results From Stage 1 of the NAVAL-1 Trial At The 2024 Annual Congress Of The Hematology Society Of Taiwan

By Benzinga Newsdesk

April 1, 8:34 AM

Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that topline

VIRX

Gilead Sciences And Meharry Medical College Highlight Five-Year Impact Of Gilead COMPASS Initiative On HIV In The Southern United States

By Happy Mohamed

August 18, 12:01 PM

– Journal Of Health Care for the Poor and Underserved Supplement Details COMPASS Progress at the Halfway Mark of the Ten-Year Initiative – Gilead Sciences, Inc. (NASDAQ:GILD) and Meharry Medical

GILD

Bitcoin Spot ETFs Notch $154M Inflows As Popular Bitcoiner Slams Ethereum: ‘A Speculative Platform For Gambling’

By Murtuza Merchant

May 23, 7:02 AM

Bitcoin spot exchange-traded funds (ETFs) continue to attract significant investor interest, with total net inflows exceeding $154 million on May 22.

BTC

What’s Going On With TC BioPharm Stock?

By Adam Eckert

January 18, 10:19 AM

Shares of clinical-stage biopharmaceutical company TC BioPharm Plc (NASDAQ: TCBP) are continuing to trade higher Wednesday after the company on Tuesday announced a strategic collaboration to

TCBP

Dollar Tree Executive Says In Q2, Consumables Comps Increased 4% While Discretionary Comps Declined 4.1%

Related Posts

Viracta Therapeutics To Present Topline Nana-val Results From Stage 1 of the NAVAL-1 Trial At The 2024 Annual Congress Of The Hematology Society Of Taiwan

Gilead Sciences And Meharry Medical College Highlight Five-Year Impact Of Gilead COMPASS Initiative On HIV In The Southern United States

Bitcoin Spot ETFs Notch $154M Inflows As Popular Bitcoiner Slams Ethereum: ‘A Speculative Platform For Gambling’

What’s Going On With TC BioPharm Stock?